×

Health Care Equipment and Supplies Health Care Equipment

  • Sept 5- Medical device maker Teleflex Inc said on Tuesday it would buy privately held NeoTract Inc in its second billion-dollar deal in the past nine months, to strengthen its portfolio of urology devices. Teleflex, which also makes emergency care, respiratory and cardiac devices, said the deal's value could rise to $1.1 billion based on sales of NeoTract's sole...

  • Sept 5- Medical device maker Teleflex Inc said on Tuesday it would buy privately held NeoTract Inc to strengthen its portfolio of urology devices in its second billion-dollar deal in the past nine months. The company's revenue is expected to be between $115 million and $120 million this year, compared with about $51 million in 2016, and is estimated to increase...

  • Sept 5- Medical device maker Teleflex Inc said on Tuesday it would buy privately-held NeoTract Inc in a deal valued at up to $1.1 billion to strengthen its portfolio of urology devices. The company's devices are used in urology, cardiac, respiratory and emergency care, and in December last year it strengthened its coronary and vascular business with the $1...

  • NEW YORK, Aug 29- Abbott Laboratories said on Tuesday it would issue updates to reduce the risk of its St. Jude recalled some of its 400,000 implanted heart devices last October due to risk of premature battery depletion, which was linked to two deaths in Europe. The U.S. Food and Drug Administration said then that hospitals should return unused devices and warned...

  • NEW YORK, Aug 29- Abbott Laboratories said on Tuesday it will issue updates to reduce the risk of its St. Jude recalled some of its 400,000 implanted heart devices last October due to risk of premature battery depletion, which was linked to two deaths in Europe. The U.S. Food and Drug Administration said then that hospitals should return unused devices and warned...

  • NEW YORK, Aug 29- Abbott Laboratories said on Tuesday it will issue updates to reduce the risk of its St. Jude recalled some of its 400,000 implanted heart devices last October due to risk of premature battery depletion, which was linked to two deaths in Europe. The U.S. Food and Drug Administration said then that hospitals should return unused devices and warned...

  • Cramer Remix: Amazon is finally facing a real rival

    Jim Cramer's telling you why Amazon could finally be feeling the heat.

  • Jim Cramer on Mad Money.

    Jim Cramer’s telling you why Amazon could finally be feeling the heat.

  • *1st- qtr rev $7.39 bln vs est $7.45 bln. Shares of the Dublin- based company, which makes heart devices, spinal implants and insulin pumps, dipped as much as 3 percent to $81.00 in morning trading. Sales in Medtronic's diabetes business, which includes artificial pancreas devices and insulin pumps, fell about 1 percent to $449 million in the first quarter ended July...

  • Net income attributable to Medtronic rose to $1.02 billion, or 74 cents per share in the first quarter ended July 28, from $929 million, or 66 cents per share, a year earlier. Net sales climbed 3.1 percent to $7.39 billion. Dublin- based Medtronic generates most of its sales from heart devices, spinal implants and insulin pumps.

  • NEW DELHI, Aug 16- India has capped prices of orthopaedic knee implants, in the country's latest move to bring down prices of medical devices. India's drug pricing authority said on Wednesday that orthopaedic implants in India had unjustified, unreasonable and irrationally high trade margins, leading to exorbitant pricing. Major international...

  • NEW DELHI, Aug 16- India has capped prices of orthopaedic knee implants, in the country's latest move to bring down prices of medical devices. India's drug pricing authority said on Wednesday that orthopaedic implants in India had unjustified, unreasonable and irrationally high trade margins, leading to exorbitant pricing. Major pharmaceutical companies...

  • NEW DELHI, Aug 16- India has capped prices of orthopaedic knee implants, in the country's latest move to bring down prices of medical devices. India's drug pricing authority said on Wednesday that orthopaedic implants in India had unjustified, unreasonable and irrationally high trade margins, leading to exorbitant pricing. Major pharmaceutical companies...

  • NEW DELHI, Aug 16- India has capped prices of orthopedic knee implants, in the country's latest move to bring down prices of medical devices. India's drug pricing authority said on Wednesday that orthopedic implants in India had unjustified, unreasonable and irrationally high trade margins, leading to exorbitant pricing. Major pharmaceutical companies have...

  • NEW DELHI, Aug 16- India has capped prices of orthopedic knee implants, in the country's latest move to bring down prices of medical devices. India's drug pricing authority said on Wednesday that orthopedic implants in India had unjustified, unreasonable and irrationally high trade margins, leading to exorbitant pricing. Major pharmaceutical companies have...

  • Stryker CEO: For us it's always about innovation in medtech

    Kevin Lobo, Stryker CEO, talks the company's mission to provide high-tech, innovative devices for treating patients, including robotic assistance in the operating room.

  • REPUBLICAN SENATE HEALTHCARE BILL REPEALS MEDICAL DEVICES TAX THROUGH DEC. 31, 2020.

  • To bolster its position in the TAVR market in Europe, Boston Scientific in May bought Swiss medical device maker Symetis SA- the fourth-largest player in the multi-billion dollar market- for $435 million. The deal came after Boston Scientific's February recall of its Lotus heart valve devices from Europe and other regions following reports of a faulty...

  • Sales in Boston Scientific's cardiovascular unit- its biggest by revenue- rose 4.7 percent to $876 million in the second quarter ended June 30. Boston Scientific, which closed a $435 million acquisition of Swiss medical device maker Symetis SA in May, posted net profit of $146 million, or 11 cents per share, compared with a net loss of $207 million, or 15 cents per...

  • July 27- Medical device maker Boston Scientific Corp on Thursday posted a profit in the second quarter compared with a year-ago loss, helped by higher sales as well as lower litigation-related expenses. The company posted a net profit of $146 million, or 11 cents per share in the quarter ended June 30, compared with a net loss of $207 million, or 15 cents per share, a...